期刊文献+

广东省各区域公众用药安全意识与行为比较分析 被引量:3

Comparative Analysis of Public Awareness of Drug Safety and Behaviors in Various Regions of Guangdong Province
下载PDF
导出
摘要 目的通过对广东省各区域公众用药安全意识与行为的调查结果进行比较,找出各区域存在的主要差异,为公众安全用药教育提供依据。方法采用现场填写并回收问卷的方法,对珠三角、粤东、粤西、粤北4个区域的普通公众进行调查,共发放问卷5078份,回收有效问卷3486份。使用SPSS 13.0进行数据录入、整理和分析。结果与结论广东省4个区域的公众用药安全意识与行为存在明显差异:粤北地区在"无医生指导下会不会擅自同时服用几种药品"问题上,选择不会的只有25.6%;粤西地区在"听从医生"或"出现不良反应"为停止用药依据的情况只有27.8%。应对粤北地区着重加强用药安全意识教育,粤西地区需对用药安全行为加大宣传普及力度。 Objective To identify major differences existing in each region,and to provide a basis to strengthen the regional public safety medication education through the comparison of public awareness of drug safety and the behavior in the various regions of Guangdong Province investigated by questionnaire.Methods Questionnaires were filled out on site among the general public of the four regions of the Pearl River Delta,eastern,western,and northern Guangdong.A total of 5078 questionnaires were distributed,of which 3486 copies were valid questionnaires.SPSS 13.0 was used for data entry,collation and analysis.Results and Conclusion There were significant differences in public awareness of drug safety and behavior of the four regions in Guangdong Province.In northern Guangdong,on the issue of " whether taking different drugs at the same time without a doctor's guidance",only 25.6% chose " no";in western Guangdong,only 27.8% took " follow the doctor's instruction" or " adverse reactions" as the drug withdrawal basis.It is suggested to strengthen drug safety awareness education in northern Guangdong,and to increase publicity and popularization of medication safety behavior in western region.
作者 刘佐仁 钱扬
出处 《中国药事》 CAS 2012年第12期1297-1300,共4页 Chinese Pharmaceutical Affairs
基金 广东省软科学研究项目(编号2011B070300055)
关键词 用药意识 用药行为 用药教育 区域比较 the awareness of drug-using the behavior of drug-using medication education regional comparison
  • 相关文献

参考文献3

二级参考文献6

共引文献10

同被引文献25

  • 1克林霉素磷酸酯产品简介[J].现代妇产科进展,2006,15(3):239-239. 被引量:1
  • 2邓玲,邓盛齐.克林霉素国内外制剂的研究进展[J].西南国防医药,2006,16(2):222-224. 被引量:9
  • 3卫生部,国家食品药品监督管理局.药品不良反应报告和监测管理办法[EB/OL]http://www.sda.gov.cn/WS01/CL0053/24477.html.2010-06-02.
  • 4夏振华,秦赟,王明珊.克林霉素磷酸酯的“不良反应”——解析“克林霉素磷酸酯”生产工艺和质量标准[J].抗感染药学,2007,4(3):138-139. 被引量:9
  • 5国家食品药品监督管理总局.国家药品不良反应监测年度报告(2013年)[EB/OL].2014-05-14.http://www.sds.gov.en/WS01/CL0078/99794.html.
  • 6de Langen J, van Hunsel F, Passier A, et al. Adverse drug reaction reporting by patients in the Netherlands: three years of experience[J]. Drug Safety, 2008, 31 (6) : 515-524.
  • 7Lise Aagaard, Lars Hougaard Nielsen, Ebba Holme Hansen. Consumer Reporting of Adverse Drug Reactions : a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006 [J]. Drug Safety, 2009, 32 (ll) : 1067-1074.
  • 8Hazell L, Cornelius V, Hannaford P, et al. How do patients contribute tO signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme[J]. Drug Safety, 2013,36 (3) : 199-206.
  • 9Leone R, Moretti U. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study[J]. Drug Safety, 2013, 36 (4) : 267-276.
  • 10国务院办公厅.关于进一步加强食品药品安全监管工作的通知[z].(国办发[2007118号),2007.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部